Ligand’s Fourth Quarter Financial Results to be Reported February 3rd

Go back to Ligand’s Fourth Quarter Financial Results to be Reported February 3rd
LIGAND PHARMA (NASDAQ: LGND) Delayed: 296.45 +0.19 (0.06%)
Previous Close $296.26    52 Week High $139.79 
Open $295.11    52 Week Low $82.07 
Day High $303.58    P/E 689.42 
Day Low $293.67    EPS $0.43 
Volume 241,733